Basics |
STAAR Surgical Company
Staar Surgical along with its subsidiaries designs, develops, manufactures and sells implantable lenses and delivery systems for the eye. The Company develops, produces, and markets intraocular lenses.
|
IPO Date: |
March 2, 1992 |
Sector: |
Healthcare |
Industry: |
Health Care Equipment and Supplies |
Market Cap: |
$1.38B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.56 | 2.46%
|
Avg Daily Range (30 D): |
$0.24 | 1.00%
|
Avg Daily Range (90 D): |
$0.35 | 1.81%
|
Institutional Daily Volume |
Avg Daily Volume: |
.27M |
Avg Daily Volume (30 D): |
2.2M |
Avg Daily Volume (90 D): |
1.15M |
Trade Size |
Avg Trade Size (Sh.): |
79 |
Avg Trade Size (Sh.) (30 D): |
140 |
Avg Trade Size (Sh.) (90 D): |
87 |
Institutional Trades |
Total Inst.Trades: |
3,546 |
Avg Inst. Trade: |
$2.77M |
Avg Inst. Trade (30 D): |
$2.42M |
Avg Inst. Trade (90 D): |
$2.37M |
Avg Inst. Trade Volume: |
.06M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$3.4M |
Avg Closing Trade (30 D): |
$3.69M |
Avg Closing Trade (90 D): |
$2.97M |
Avg Closing Volume: |
69.81K |
|
|
Financials |
|
TTM |
Q2 2025 |
Q1 2025 |
Basic EPS
|
$-1.94
|
$-.34
|
$-1.1
|
Diluted EPS
|
$-1.93
|
$-.34
|
$-1.1
|
Revenue
|
$ 224.45M
|
$ 44.32M
|
$ 42.59M
|
Gross Profit
|
$ 160.94M
|
$ 32.8M
|
$ 28.01M
|
Net Income / Loss
|
$ -95.27M
|
$ -16.81M
|
$ -54.21M
|
Operating Income / Loss
|
$ -109.59M
|
$ -29.96M
|
$ -57.4M
|
Cost of Revenue
|
$ 63.51M
|
$ 11.52M
|
$ 14.58M
|
Net Cash Flow
|
$ -25.65M
|
$ -5.98M
|
$ 28.96M
|
PE Ratio
|
|
|
|
|
|
|